HPTN Publications

Momplaisir, F., Hussein, M., Tobin-Fiore, D., Smith, L., Bennett, D., Latkin, C., Metzger, D. S. . Racial Inequities in HIV Prevalence and Composition of Risk Networks Among People Who Inject Drugs in HIV Prevention Trial Network 037. J Acquir Immune Defic Syndr. 2018, 76: 394-401

Montgomery BE, Rompalo A, Hughes J, Wang J, Haley D, Soto-Torres L, Chege W, Justman J, Kuo I, Golin C, Frew P, Mannheimer S, Hodder S . Violence Against Women in Selected Areas of the United States. Am J Public Health. 2015, 105: 2156-66

Moore HP, Palumbo PJ, Notarte KI, Fogel JM, Cummings V, Gamble T, Del Rio C, Batey DS, Mayer KH, Farley JE, Remien RH, Beyrer C, Hudelson SE, Eshleman SH . Performance of the Applied Biosystems HIV-1 Genotyping Kit with Integrase. J Clin Microbiol. 2024, 62: e0013624

Moore JR, Donnell DJ, Boily MC, Mitchell KM, Delany-Moretlwe S, Bekker LG, Mgodi NM, El-Sadr W, Cohen MS, Celum CL, Dimitrov D . Model-Based Predictions of HIV Incidence Among African Women Using HIV Risk Behaviors and Community-Level Data on Male HIV Prevalence and Viral Suppression [HPTN 082]. Journal of Acquired Immune Deficiency Syndromes. 2020, 85: 423-429

Moshoette T, Papathanasopoulos MA, Killick MA . HIV-1 bispecific antibody iMab-N6 exhibits enhanced breadth but not potency over its parental antibodies iMab and N6. J Virol. 2022, 19: 143

Mubekapi-Musadaidzwa C, Wademan D, Peton N, Hendricks P, Carolus G, Mbaezue R, Kelley KF, Kruger J, Jennings K, Grobbelaar N, Louis F, Beyers N, Ayles H, Fidler S, Hayes R, Bock P, Hoddinott G . Motivating people living with HIV to initiate antiretroviral treatment outside national guidelines in three clinics in the HPTN 071 (PopART) trial, South Africa. 2021

Mulubwa C, Hensen B, Phiri MM, Shanaube K, Schaap AJ, Floyd S, Phiri CR, Bwalya C, Bond V, Simwinga M, Mwenge L, Fidler S, Hayes R, Mwinga A, Ayles H, for the HPTN 071 Study Team . Community based distribution of oral HIV self-testing kits in Zambia: a cluster-randomised trial nested in four HPTN 071 (PopART) intervention communities. Lancet HIV. 2019, 6: e81-e92

Myron S. Cohen, Lawrence Corey, Cohen MS, Corey L . Broadly neutralizing antibodies to prevent HIV-1. 2017, 358: 46-47